Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Gentzler RD"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maheshwari S; Division of Hematology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Gentzler RD; Division of Hematology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA.
Publikováno v:
Journal of thoracic disease [J Thorac Dis] 2024 Sep 30; Vol. 16 (9), pp. 6342-6346. Date of Electronic Publication: 2024 Sep 23.
Autor:
Wessel RE; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Ageeb N; Department of Biology, University of Virginia, Charlottesville, Virginia, USA., Obeid JM; Department of Thoracic Surgery, Temple University Hospital, Philadelphia, Pennsylvania, USA., Mauldin IS; Department of Surgery, University of Virginia, Charlottesville, Virginia, USA., Goundry KA; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Hanson GF; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA., Hossain M; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA., Lehman C; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA., Gentzler RD; Department of Medicine, Hematology and Oncology, University of Virginia, Charlottesville, Virginia, USA., Wages NA; Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, USA., Slingluff CL Jr; Department of Surgery, University of Virginia, Charlottesville, Virginia, USA., Bullock TNJ; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA.; Department of Pathology, University of Virginia, Charlottesville, Virginia, USA., Dolatshahi S; Department of Biomedical Engineering, University of Virginia, Charlottesville, Virginia, USA sdolatshahi@virginia.edu.; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA., Brown MG; Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA.; Department of Medicine, Nephrology Division, University of Virginia, Charlottesville, Virginia, USA.; Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia School of Medicine, Charlottesville, Virginia, USA.; Department of Microbiology, Immunology and Cancer Biology, Univesity of Virginia, School of Medicine, Charlottesville, Virginia, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Sep 18; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 18.
Autor:
Gentzler RD; Department of Hematology and Oncology, University of Virginia, Charlottesville, VA, USA., Guittar J; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Mitra A; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Iams WT; Division of Hematology/Oncology, Vanderbuilt-Ingram Cancer Center, Nashville, TN, USA., Driessen T; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Schwind R; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Stein MM; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Kaneva K; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Hyun SW; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Liu Y; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Dugan AJ; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Vibat CRT; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Sangli C; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Freaney J; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Rivers Z; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Feliciano JL; Hematology Oncology, John Hopkins Bayview Medical Center, Baltimore, MD, USA., Lo C; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Sasser K; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Ben-Shachar R; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA. rotem.benshachar@tempus.com., Nimeiri H; Tempus AI, Inc., 600 West Chicago Avenue, Suite 510, Chicago, IL, 60654, USA., Patel JD; Department of Medicine, Northwestern University, Evanston, IL, USA., Chaudhuri AA; Department of Radiation Oncology, Washington University in St. Louis, St. Louis, MO, USA.
Publikováno v:
Oncology and therapy [Oncol Ther] 2024 Sep; Vol. 12 (3), pp. 509-524. Date of Electronic Publication: 2024 Jul 22.
Autor:
Neal JW; Division of Oncology, Stanford Cancer Institute, Palo Alto, California., Santoro A; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; IRCCS Humanitas Research Hospital- Humanitas Cancer Center, Rozzano, Milan, Italy., Gonzalez-Cao M; Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain., Lim FL; Barts Health NHS Trust, St Bartholomew's Hospital, London, United Kingdom., Fang B; Astera Cancer Care, East Brunswick, New Jersey., Gentzler RD; Division of Hematology Oncology, University of Virginia Cancer Center, Charlottesville, Virginia., Goldschmidt J; Department of Medical Oncology, Blue Ridge Cancer Care, Blacksburg, Virginia., Khrizman P; MD Anderson Cancer Center at Cooper, Camden, New Jersey., Proto C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy., Patel S; Division of Medical Oncology, The Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah., Puri S; Division of Medical Oncology, The Huntsman Cancer Institute at the University of Utah, Salt Lake City, Utah., Liu SV; Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia., Massarelli E; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California., Williamson D; Department of Biostatistics, Exelixis Inc, Alameda, California., Schwickart M; Department of Translational Medicine, Exelixis Inc, Alameda, California., Scheffold C; Department of Clinical Development, Exelixis Inc, Alameda, California., Andrianova S; Department of Clinical Development, Exelixis Inc, Alameda, California., Felip E; Medical Oncology Service, Vall d'Hebron Institute of Oncology (VIHO), Vall d'Hebron Barcelona Hospital Campus, Universitat Autonoma de Barcelona, Barcelona, Spain.
Publikováno v:
JTO clinical and research reports [JTO Clin Res Rep] 2024 Mar 20; Vol. 5 (10), pp. 100666. Date of Electronic Publication: 2024 Mar 20 (Print Publication: 2024).
Autor:
Gentzler RD; Department of Medicine, Division of Hematology/Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA., Mohindra NA; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Jalal SI; Department of Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Reckamp KL; Department of Medicine, Division of Medical Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Hall RD; Department of Medicine, Division of Hematology/Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA., Hanna NH; Department of Medicine, Division of Hematology/Oncology, Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN, USA., Chae YK; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Koczywas M; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Helenowski IB; Department of Preventive Medicine, Northwestern University, Chicago, IL, USA., Patel JD; Department of Medicine, Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Publikováno v:
The oncologist [Oncologist] 2024 Jan 05; Vol. 29 (1), pp. 47-56.
Autor:
Young P; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22903, USA., Elghawy O; School of Medicine, University of Virginia, Charlottesville, VA 22903, USA., Mock J; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22903, USA., Wynter E; Department of Medicine, University of Virginia, Charlottesville, VA 22903, USA., Gentzler RD; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22903, USA., Martin LW; Department of Surgery, Division of Thoracic and Cardiovascular Surgery, University of Virginia, Charlottesville, VA 22903, USA., Novicoff W; Department of Public Health Sciences and Orthopedic Surgery, University of Virginia, Charlottesville, VA 22903, USA., Hall R; Department of Medicine, Division of Hematology/Oncology, University of Virginia, Charlottesville, VA 22903, USA.
Publikováno v:
Current oncology (Toronto, Ont.) [Curr Oncol] 2024 Jan 03; Vol. 31 (1), pp. 260-273. Date of Electronic Publication: 2024 Jan 03.
Autor:
Passaro A; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy. Electronic address: antonio.passaro@ieo.it., Wang J; Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China., Wang Y; Department of Thoracic Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, Chengdu, China., Lee SH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Melosky B; British Columbia Cancer Agency, Vancouver, Canada., Shih JY; Department of Internal Medicine, National Taiwan University Hospital, Taipei City, Taiwan., Wang J; Fudan University Shanghai Cancer Center, Shanghai, China., Azuma K; Kurume University School of Medicine, Kurume, Japan., Juan-Vidal O; Hospital Universitari i Politécnic La Fe, Valencia, Spain., Cobo M; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, IBIMA, Málaga, Spain., Felip E; Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain., Girard N; Institut Curie, Institut du Thorax Curie-Montsouris, Paris, France; Paris Saclay University, UVSQ, Versailles, France., Cortot AB; University of Lille, CHU Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020-UMR1277-Canther-Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille, France., Califano R; Department of Medical Oncology, Christie NHS Foundation Trust and Division of Cancer Sciences, The University of Manchester, Manchester, UK., Cappuzzo F; IRCCS Regina Elena National Cancer Institute, Rome, Italy., Owen S; Department of Medical Oncology, McGill University Health Centre, Montreal, Quebec, Canada., Popat S; Royal Marsden Hospital NHS Foundation Trust and The Institute of Cancer Research, London, UK., Tan JL; Department of Medicine, University of Malaya, Kuala Lumpur, Malaysia., Salinas J; Centro de Especialidades Medicas Ambulatorias e Investigación Clínica, Córdoba, Argentina., Tomasini P; Multidisciplinary Oncology and Therapeutic Innovations Department, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille University, Marseille, France., Gentzler RD; Hematology/Oncology, University of Virginia Cancer Center, Charlottesville, VA, USA., William WN Jr; Centro Oncológico BP, Beneficência Portuguesa de São Paulo, and Grupo Oncoclínicas, São Paulo, Brazil., Reckamp KL; Cedars-Sinai Medical Center, Los Angeles, USA., Takahashi T; Division of Thoracic Oncology, Shizuoka Cancer Center, Nagaizumi, Japan., Ganguly S; Tata Medical Center, Kolkata, India., Kowalski DM; Department of Lung Cancer and Thoracic Tumours, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Bearz A; Medical Oncology, Centro di Riferimento Oncologico-CRO, Aviano, Italy., MacKean M; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK., Barala P; Janssen Research & Development, Spring House, PA, USA., Bourla AB; Janssen Research & Development, Raritan, NJ, USA., Girvin A; Janssen Research & Development, Spring House, PA, USA., Greger J; Janssen Research & Development, Spring House, PA, USA., Millington D; Janssen Research & Development, San Diego, CA, USA., Withelder M; Janssen Research & Development, Spring House, PA, USA., Xie J; Janssen Research & Development, Raritan, NJ, USA., Sun T; Janssen Research & Development, Raritan, NJ, USA., Shah S; Janssen Research & Development, Spring House, PA, USA., Diorio B; Janssen Research & Development, Raritan, NJ, USA., Knoblauch RE; Janssen Research & Development, Spring House, PA, USA., Bauml JM; Janssen Research & Development, Spring House, PA, USA., Campelo RG; University Hospital A Coruña, A Coruña, Spain., Cho BC; Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jan; Vol. 35 (1), pp. 77-90. Date of Electronic Publication: 2023 Oct 23.
Autor:
Gentzler RD; Division of Hematology/Oncology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Villaruz LC; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Medical Center-Hillman Cancer Center, Pittsburgh, PA, USA., Rhee JC; Division of Hematology/Oncology, Department of Medicine, University of Pittsburgh Medical Center-Hillman Cancer Center, Pittsburgh, PA, USA., Horton B; Department of Public Health Sciences, University of Virginia School of Medicine, Charlottesville, VA, USA., Mock J; Division of Hematology/Oncology, Department of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Hanley M; Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA., Kim K; Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Rudek MA; Department of Oncology and Medicine, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Phelps MA; Division of Pharmaceutics & Pharmacology, College of Pharmacy, The Ohio State University, Columbus, OH, USA., Carducci MA; Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Piekarz R; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Park KS; Department of Microbiology, Immunology, and Cancer Biology, School of Medicine, University of Virginia Cancer Center, Charlottesville, VA, USA., Bullock TN; Department of Pathology, University of Virginia Cancer Center, Charlottesville, VA, USA., Rudin CM; Department of Medicine, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
The oncologist [Oncologist] 2023 Nov 02; Vol. 28 (11), pp. 1007-e1107.